LMAT Lemaitre Vascular PE ratio, current and historical analysis

?
Relative Growth: Rel. Growth: 95
Relative Strength: Rel. Strength: 19
Relative Valuation: Rel. Valuation: 45
Relative Profitability: Rel. Profitability: 91

As of Aug 21, 2026, the Lemaitre Vascular stock's price-to-earnings ratio is 28.23. This results from the current EPS of $2.9 and stock price of $81.86. The PE ratio has decreased by 20% from the past four quarters average of 35.3.

LMAT PE ratio history

How has LMAT's PE ratio performed in the past

The PE ratio of Lemaitre Vascular has averaged 39.73 over the last ten years. The current price-to-earnings ratio of 28.23 is 29% less than the historical average. In the past ten years, LMAT's PE ratio reached its highest point in the Jun 2023 quarter at 59.02, when the stock price was $67.28 and the EPS was $1.14. The lowest point was recorded in the Dec 2018 quarter, when it reached 20.03 with a price of $23.64 and an EPS of $1.18.

Today
28.23
Average
39.73
Median
39.55
Minimum
20.03
Maximum
59.02

Lemaitre Vascular PE ratio by year

Maximum annual increase: 137.32% in 2011

Maximum annual decrease: -42.76% in 2018

Year PE ratio PE change Price EPS
2025 31.8 -32.35% $81.1 $2.55
2024 47.01 12.63% $92.14 $1.96
2023 41.74 -14.75% $56.76 $1.36
2022 48.96 23.79% $46.02 $0.94
2021 39.55 2.54% $50.23 $1.27
2020 38.57 -2.38% $40.5 $1.05
2019 39.51 97.25% $35.95 $0.91
2018 20.03 -42.76% $23.64 $1.18
2017 34.99 -21.3% $31.84 $0.91
2016 44.46 13.42% $25.34 $0.57
2015 39.2 22.96% $17.25 $0.44
2014 31.88 -16.41% $7.65 $0.24
2013 38.14 12.97% $8.01 $0.21
2012 33.76 -20.17% $5.74 $0.17
2011 42.29 137.32% $5.92 $0.14

Lemaitre Vascular PE ratio by quarter (TTM)

Year PE ratio PE change Price EPS
Jun 2026 33.09 -16.33% $95.96 $2.9
Mar 2026 39.55 24.37% $109.17 $2.76
Dec 2025 31.8 -13.87% $81.1 $2.55
Sep 2025 36.92 -6.65% $87.51 $2.37
Jun 2025 39.55 -4.77% $83.05 $2.1
Mar 2025 41.53 -11.66% $83.9 $2.02
Dec 2024 47.01 -5.87% $92.14 $1.96
Sep 2024 49.94 3.18% $92.89 $1.86
Jun 2024 48.4 11.6% $82.28 $1.7
Mar 2024 43.37 3.91% $66.36 $1.53
Dec 2023 41.74 -5.76% $56.76 $1.36
Sep 2023 44.29 -24.96% $54.48 $1.23
Jun 2023 59.02 7.78% $67.28 $1.14
Mar 2023 54.76 11.85% $51.47 $0.94
Dec 2022 48.96 -6.3% $46.02 $0.94

LMAT Price vs fair value

How does LMAT's price compare to its estimated fair value based on its growth

LMAT average PE ratio chart

What is the average PE ratio of LMAT for the past years

Currently, LMAT's PE ratio is lower than the 3, 5 and 10-year averages.

3-year avg
41.43
5-year avg
43.64
10-year avg
39.73
15-year avg
38.36

PE comparison

With a P/E of 28.23, LMAT stands above the Healthcare sector average but below the industry average. Looking at its Healthcare sector average of 24.52, Lemaitre Vascular's P/E is 15% higher.

LMAT PE vs peers

What is LMAT's PE ratio compared to its peers

Frequently asked questions

What is Lemaitre Vascular's PE ratio?

LMAT stock has a price to earnings ratio of 28.23 as of Aug 21, 2026.

What is the 3-year average PE ratio for Lemaitre Vascular (LMAT)?

The average PE ratio for LMAT stock over the past 3 years is 41.43.

What is the 5-year average PE ratio for Lemaitre Vascular (LMAT)?

The average PE ratio for LMAT stock over the past 5 years is 43.64.

What is the highest PE ratio for LMAT?

Over the last ten years, the quarterly PE ratio reached a historic high of 59.02 in the Jun 2023 quarter.

How does the current PE ratio for LMAT compare to its historical average?

LMAT's price to earnings ratio is currently 29% below its 10-year historical average.

How is LMAT's PE ratio calculated (Lemaitre Vascular PE ratio formula)?

You can calculate the P/E ratio by dividing the most recent stock price by the trailing twelve months earnings per share(EPS). As of today (Aug 21, 2026), Lemaitre Vascular's stock price is $81.86. The earnings per share for the trailing twelve months (TTM) ending Jun 2026 is $2.9. Therefore, Lemaitre Vascular's price to earnings ratio for today is 28.23. PE RATIO(28.23) = STOCK PRICE($81.86) / TTM EPS($2.9)

All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.